Acknowledgements PRIMA-1MET The authors gratefully acknowledge the technical assistance of YuanTai biology company of Changsha China and thank Dr Deng Xiao-Hua thoughtful insights and discussions, and for critical reading of the manuscript. This work was supported by Natural Science Foundation of Hunan IWR-1 Province of China (07JJ5094), Technology Plan Project from Science and Technology
Committee of Human Province (2007FJ4158, 2007SK3028). References 1. Parkin D Maxwell, Bray Freddie, Ferlay Jacques, Pisani Paola: Estimating the world burden: Globocan 2000[J]. Int J cancer 2001,94(2):153–156.PubMedCrossRef 2. Ding MA, Ling XI: Epidemiology and etiology research progress of Cervical Cancer. Journal of Practical Obstetrics and Gynecology 2001,17(02):61–62. 3. Russell JM, Blair V, Hunter RD: Cervical carcinoma: Prognosis in younger patients[J]. Br Med J 1987, 295:300.CrossRef 4. Wenhua
Zhang, Ping Bai, Shaokang Ma: Carcinoma of the cervix in younger women (≤ 35 year). Chinese Journal of Clinical Oncology and Rehabilitation 1999,6(6):39–41. 5. Elliott PM, Tattersall MH, Coppleson M, Russell P, Wong F, Coates AS, Solomon HJ, Bannatyne PM, Atkinson KH, Murray JC: Changing character of cervical cancer in young women[J]. Br Stattic Med J 1989,298(2):288–290.CrossRef 6. Thomas DB, Ray RM, Qin Q: Risk factors for progression of squamous cell cervical carcinoma in-situ to invasive cervical cancer:results of a multinational study[J]. Cancer Causes Control 2002,13(7):683–690.PubMedCrossRef 7. Ursin G, Pike MC, Preston-Martin S, d’Ablaing G, Peters Interleukin-3 receptor RK: Sexual, reproductive and other risk factors for adenocarcinoma of the cervix, results from a population based control study(California, united states) [J]. Cancer Causes Control 1996,7(3):391–401.PubMedCrossRef 8. CAO Ze-yi: The First Cervical Diseases Academic Conference of Chinese Medical Association. 2002, 36–39. 9. Reddy VG, Khanna N, Jain SK, Das
BC, Singh N: Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer 2001,11(2):100–106.PubMedCrossRef 10. Riethdorf S, Riethdorf L, Schulz G, Ikenberg H, Janicke F, Loning T, Park TW: Relationship between telomerase activation and HPV16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Int J Gynecol Pathol 2001,20(2):177–185.PubMedCrossRef 11. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, Doeberitz MV: p16(1NK4a) immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Patho 2002,26(11):1389–1399.CrossRef 12. Murphy N, Ring M, Heffron CCBB, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O’Leary JJ: p161NK4a, CDC6, and MCM5:predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.